Markus Gulilat
University of Toronto(CA)
Publications by Year
Research Areas
Atrial Fibrillation Management and Outcomes, Pharmacogenetics and Drug Metabolism, Genomics and Rare Diseases, Heart Failure Treatment and Management, Venous Thromboembolism Diagnosis and Management
Most-Cited Works
- → Targeted next generation sequencing as a tool for precision medicine(2019)93 cited
- → The Role of Next-Generation Sequencing in Pharmacogenetics and Pharmacogenomics(2018)74 cited
- → Interpatient Variation in Rivaroxaban and Apixaban Plasma Concentrations in Routine Care(2017)59 cited
- → Drug interactions and pharmacogenetic factors contribute to variation in apixaban concentration in atrial fibrillation patients in routine care(2019)48 cited
- → Apixaban Concentrations with Lower than Recommended Dosing in Older Adults with Atrial Fibrillation(2019)21 cited
- → Association of Sex With Stroke and Bleeding Risk of Apixaban and Rivaroxaban in Elderly Atrial Fibrillation Patients Using Propensity Score Weights(2021)9 cited
- → Pain management in adult patients with sickle cell disease in the emergency department: how does current practice compare with existing standards of care?(2023)5 cited
- → Prospective cohort study of the impact of hospital-wide dihydropyrimidine dehydrogenase (DPYD) genotype testing for fluoropyrimidine-based chemotherapy on adverse events and hospital costs.(2019)1 cited
- → Additional file 1: of Targeted next generation sequencing as a tool for precision medicine(2019)
- → Elucidating the Impact of Genetic Variation in Bile Acid Transporters on Bile Acid Signaling and Xenobiotic Transport(2017)